SmartTRAK reports that pricing pressure and a slow down in elective procedures impacted the Extremities market overall, with US Market growth down sequentially from +4.7% seen in Q318 to +3.5% in Q418. The Extremities market no longer seems to be able to fly under the radar and, as healthcare facilities look to maximize reimbursement in all areas, pricing for legacy products are facing discounting. In addition to pricing pressure, economic uncertainty in the US during Q4 led to some healthcare consumers choosing to put off elective procedures...
Among the many topics covered in the Q418/FY18 Extremities Market Recap:
- Detailed Extremities Market Overview
- Extremities Fixation: Another Tough Quarter for the Usually Robust Segment
- Shoulder Market: Healthy Growth Against a Difficult YoY Comp
- Ankle Replacement Growth: Riding the Wave
- Q418 Regulatory Highlights
The WW Market for Foot & Ankle Fixation was up +2.4% with no major YoY market share shifts for major players according to BioMedGPS’ SmartTRAK Financial Dashboard. The US Foot & Ankle Fixation market primarily drove growth during the quarter, up +3.0% as reported. The segment bucked historical trends by posting a year end dip in growth rather than the typical Q4 uptick. Tough comps in Q417 (+7.9% US growth), pricing pressure and market leaders posting more moderate growth in H218.
The US Shoulder Replacement market continued to experience relatively healthy growth in Q4, up +5.0%, and after the surge in US Ankle Replacement market growth in 2017, the market now seems to be riding the back side of the initial wave with Q418 up 6.3%...